New cases tested for RR-/MDR-TB (%) in Uruguay
Uruguay: New cases tested for RR-/MDR-TB was 91.0% in 2024. ▬ Flat
New cases tested for RR-/MDR-TB in Uruguay, 2006–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for new cases tested for rr-/mdr-tb in Uruguay is 91.0%, measured in 2024.
Compared with earlier readings it is up 18.2% on the previous year and up 31.9% over ten years.
Over the whole period, new cases tested for rr-/mdr-tb in Uruguay peaked at 100.0% in 2015 and was at its lowest, 36.0%, in 2010.
That places Uruguay 91st out of 192 countries with data for 2024, putting it in the middle of the range.
New cases tested for RR-/MDR-TB in Uruguay, year by year
| Year | Value | Change |
|---|---|---|
| 2006 | 90.0% | — |
| 2007 | 93.0% | +3.3% |
| 2008 | 96.0% | +3.2% |
| 2010 | 36.0% | -62.5% |
| 2011 | 75.0% | +108.3% |
| 2012 | 88.0% | +17.3% |
| 2013 | 68.0% | -22.7% |
| 2014 | 69.0% | +1.5% |
| 2015 | 100.0% | +44.9% |
| 2016 | 100.0% | +0.0% |
| 2017 | 84.0% | -16.0% |
| 2018 | 88.0% | +4.8% |
| 2019 | 79.0% | -10.2% |
| 2020 | 80.0% | +1.3% |
| 2021 | 80.0% | +0.0% |
| 2022 | 84.0% | +5.0% |
| 2023 | 77.0% | -8.3% |
| 2024 | 91.0% | +18.2% |
Uruguay compared with similar countries
- Uruguay's 91.0% is above the median for high income countries, which is 91.0%, 1.0× the median. (64 countries reporting)
- Uruguay's 91.0% is above the median for Latin America & Caribbean, which is 73.0%, 1.2× the median. (33 countries reporting)
Biggest year-on-year movements
Years where New cases tested for RR-/MDR-TB in Uruguay changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2011 | +108.3% | 36.0% | 75.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 93.0% | 90.0% | 96.0% | 3 |
| 2010s | 78.7% | 36.0% | 100.0% | 10 |
| 2020s | 82.4% | 77.0% | 91.0% | 5 |
Countries ranked near Uruguay
- 91 Netherlands 91.0% compare
- 91 United States 91.0% compare
- 91 China 91.0% compare
- 91 Myanmar 91.0% compare
- 91 Libya 91.0% compare
More health data for Uruguay
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6727 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,631 deaths per 1,000 people (2090)
- Number of infants who die before age 1 31 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.79 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0241 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.84 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is new cases tested for rr-/mdr-tb in Uruguay?
- New cases tested for rr-/mdr-tb in Uruguay was 91.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest new cases tested for rr-/mdr-tb recorded in Uruguay?
- The highest recorded value was 100.0% in 2015.
- What is the lowest new cases tested for rr-/mdr-tb recorded in Uruguay?
- The lowest recorded value was 36.0% in 2010.
- How does Uruguay rank for new cases tested for rr-/mdr-tb?
- Uruguay ranks 91st out of 192 countries with data for 2024.
- Is new cases tested for rr-/mdr-tb rising or falling in Uruguay?
- Over the last ten years it is up 31.9%. The long-run trend across the full record is flat.
- Where does this Uruguay data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of New cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).